The name of this superfamily has been modified since the most recent official CATH+ release (v4_4_0). At the point of the last release, this superfamily was named:
"High mobility group box domain
".
FunFam 6: High mobility group protein B1
Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.
There are 81 GO terms relating to "molecular function"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Four-way junction DNA binding GO:0000400
Interacting selectively and non-covalently with DNA containing four-way junctions, also known as Holliday junctions, a structure where two DNA double strands are held together by reciprocal exchange of two of the four strands, one strand each from the two original helices.
|
1055 |
A0A024RDR0 (/ISS)
A0A024RDR0 (/ISS)
A0A024RDR0 (/ISS)
A0A024RDR0 (/ISS)
A0A024RDR0 (/ISS)
A0A024RDR0 (/ISS)
A0A024RDR0 (/ISS)
A0A024RDR0 (/ISS)
A0A024RDR0 (/ISS)
A0A024RDR0 (/ISS)
(1045 more) |
DNA binding, bending GO:0008301
The activity of binding selectively and non-covalently to and distorting the original structure of DNA, typically a straight helix, into a bend, or increasing the bend if the original structure was intrinsically bent due to its sequence.
|
1040 |
A0A024RDR0 (/ISS)
A0A024RDR0 (/ISS)
A0A024RDR0 (/ISS)
A0A024RDR0 (/ISS)
A0A024RDR0 (/ISS)
A0A024RDR0 (/ISS)
A0A024RDR0 (/ISS)
A0A024RDR0 (/ISS)
A0A024RDR0 (/ISS)
A0A024RDR0 (/ISS)
(1030 more) |
Supercoiled DNA binding GO:0097100
Interacting selectively and non-covalently with supercoiled DNA. For example, during replication and transcription, template DNA is negatively supercoiled in the receding downstream DNA and positively supercoiled in the approaching downstream DNA.
|
1029 |
A0A024RDR0 (/ISS)
A0A024RDR0 (/ISS)
A0A024RDR0 (/ISS)
A0A024RDR0 (/ISS)
A0A024RDR0 (/ISS)
A0A024RDR0 (/ISS)
A0A024RDR0 (/ISS)
A0A024RDR0 (/ISS)
A0A024RDR0 (/ISS)
A0A024RDR0 (/ISS)
(1019 more) |
Bubble DNA binding GO:0000405
Interacting selectively and non-covalently with DNA that contains a bubble. A bubble occurs when DNA contains a region of unpaired, single-stranded DNA flanked on both sides by regions of paired, double-stranded DNA.
|
872 |
A0A024RDR0 (/ISS)
A0A024RDR0 (/ISS)
A0A024RDR0 (/ISS)
A0A024RDR0 (/ISS)
A0A024RDR0 (/ISS)
A0A024RDR0 (/ISS)
A0A024RDR0 (/ISS)
A0A024RDR0 (/ISS)
A0A024RDR0 (/ISS)
A0A024RDR0 (/ISS)
(862 more) |
Non-sequence-specific DNA binding, bending GO:0044378
The activity of binding selectively and non-covalently to DNA in a sequence-independent manner and distorting the original structure of DNA, typically a straight helix, into a bend, or increasing the bend if the original structure was intrinsically bent due to its sequence.
|
689 |
A0A059XNA0 (/ISS)
A0A059XNA0 (/ISS)
A0A059XNA0 (/ISS)
A0A059XNA0 (/ISS)
A0A059XNA0 (/ISS)
A0A059XNA0 (/ISS)
A0A059XNA0 (/ISS)
A0A059XNA0 (/ISS)
A0A059XNA0 (/ISS)
A0A059XNA0 (/ISS)
(679 more) |
Drug binding GO:0008144
Interacting selectively and non-covalently with a drug, any naturally occurring or synthetic substance, other than a nutrient, that, when administered or applied to an organism, affects the structure or functioning of the organism; in particular, any such substance used in the diagnosis, prevention, or treatment of disease.
|
202 |
A0A087QNV0 (/ISS)
A0A087QNV0 (/ISS)
A0A087QNV0 (/ISS)
A0A087QNV0 (/ISS)
A0A091F7A2 (/ISS)
A0A091GCL3 (/ISS)
A0A091GCL3 (/ISS)
A0A091H0T5 (/ISS)
A0A091IH21 (/ISS)
A0A091KT98 (/ISS)
(192 more) |
Enhancer sequence-specific DNA binding GO:0001158
Interacting selectively and non-covalently with a specific sequence of DNA that is part of an enhancer, a transcription regulatory region that is somewhat distal from the core promoter and which enhances transcription from that promoter.
|
180 |
A0A091GCL3 (/ISS)
A0A091GCL3 (/ISS)
A0A091H0T5 (/ISS)
A0A091KT98 (/ISS)
A0A091KT98 (/ISS)
A0A091PGF7 (/ISS)
A0A091PGF7 (/ISS)
A0A091PGF7 (/ISS)
A0A093RXY1 (/ISS)
A0A093RXY1 (/ISS)
(170 more) |
Transcription factor binding GO:0008134
Interacting selectively and non-covalently with a transcription factor, a protein required to initiate or regulate transcription.
|
180 |
A0A091GCL3 (/ISS)
A0A091GCL3 (/ISS)
A0A091H0T5 (/ISS)
A0A091KT98 (/ISS)
A0A091KT98 (/ISS)
A0A091PGF7 (/ISS)
A0A091PGF7 (/ISS)
A0A091PGF7 (/ISS)
A0A093RXY1 (/ISS)
A0A093RXY1 (/ISS)
(170 more) |
Double-stranded DNA binding GO:0003690
Interacting selectively and non-covalently with double-stranded DNA.
|
176 |
A0A096MR30 (/ISS)
A0A096MR30 (/ISS)
A0A096MR30 (/ISS)
A0A096MR30 (/ISS)
A0A2J8R9D1 (/ISS)
A0A2J8R9D1 (/ISS)
A0A2J8R9D1 (/ISS)
A0A2J8R9D1 (/ISS)
D2GUW1 (/ISS)
D2GUW1 (/ISS)
(166 more) |
Single-stranded DNA binding GO:0003697
Interacting selectively and non-covalently with single-stranded DNA.
|
151 |
A0A096MR30 (/ISS)
A0A096MR30 (/ISS)
A0A096MR30 (/ISS)
A0A096MR30 (/ISS)
A0A2J8R9D1 (/ISS)
A0A2J8R9D1 (/ISS)
A0A2J8R9D1 (/ISS)
A0A2J8R9D1 (/ISS)
D2GUW1 (/ISS)
D2GUW1 (/ISS)
(141 more) |
DNA binding GO:0003677
Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
|
131 |
A0A096MR30 (/ISS)
A0A096MR30 (/ISS)
A0A096MR30 (/ISS)
A0A096MR30 (/ISS)
A0A2J8R9D1 (/ISS)
A0A2J8R9D1 (/ISS)
A0A2J8R9D1 (/ISS)
A0A2J8R9D1 (/ISS)
D2GUW1 (/ISS)
D2GUW1 (/ISS)
(121 more) |
Damaged DNA binding GO:0003684
Interacting selectively and non-covalently with damaged DNA.
|
66 |
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
(56 more) |
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
|
56 |
P09429 (/IPI)
P09429 (/IPI)
P09429 (/IPI)
P09429 (/IPI)
P09429 (/IPI)
P09429 (/IPI)
P09429 (/IPI)
P09429 (/IPI)
P09429 (/IPI)
P09429 (/IPI)
(46 more) |
Transcription coactivator activity GO:0003713
A protein or a member of a complex that interacts specifically and non-covalently with a DNA-bound DNA-binding transcription factor to activate the transcription of specific genes. Coactivators often act by altering chromatin structure and modifications. For example, one class of transcription coregulators modifies chromatin structure through covalent modification of histones. A second ATP-dependent class modifies the conformation of chromatin. Another type of coregulator activity is the bridging of a DNA-binding transcription factor to the basal transcription machinery. The Mediator complex, which bridges transcription factors and RNA polymerase, is also a transcription coactivator.
|
45 |
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
(35 more) |
RNA binding GO:0003723
Interacting selectively and non-covalently with an RNA molecule or a portion thereof.
|
45 |
P09429 (/HDA)
P09429 (/HDA)
P09429 (/HDA)
P09429 (/HDA)
P09429 (/HDA)
P09429 (/HDA)
P09429 (/HDA)
P09429 (/HDA)
P09429 (/HDA)
P09429 (/HDA)
(35 more) |
Transcription regulatory region DNA binding GO:0044212
Interacting selectively and non-covalently with a DNA region that regulates the transcription of a region of DNA, which may be a gene, cistron, or operon. Binding may occur as a sequence specific interaction or as an interaction observed only once a factor has been recruited to the DNA by other factors.
|
45 |
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
(35 more) |
DNA binding, bending GO:0008301
The activity of binding selectively and non-covalently to and distorting the original structure of DNA, typically a straight helix, into a bend, or increasing the bend if the original structure was intrinsically bent due to its sequence.
|
42 |
F1NPU8 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
(32 more) |
Double-stranded DNA binding GO:0003690
Interacting selectively and non-covalently with double-stranded DNA.
|
35 |
F1RJ01 (/IDA)
P07746 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
(25 more) |
Lipopolysaccharide binding GO:0001530
Interacting selectively and non-covalently with lipopolysaccharide.
|
34 |
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
(24 more) |
Phosphatidylserine binding GO:0001786
Interacting selectively and non-covalently with phosphatidylserine, a class of glycophospholipids in which a phosphatidyl group is esterified to the hydroxyl group of L-serine.
|
34 |
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
(24 more) |
Damaged DNA binding GO:0003684
Interacting selectively and non-covalently with damaged DNA.
|
34 |
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
(24 more) |
Cytokine activity GO:0005125
Functions to control the survival, growth, differentiation and effector function of tissues and cells.
|
34 |
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
(24 more) |
Integrin binding GO:0005178
Interacting selectively and non-covalently with an integrin.
|
34 |
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
(24 more) |
Transcription factor binding GO:0008134
Interacting selectively and non-covalently with a transcription factor, a protein required to initiate or regulate transcription.
|
34 |
P09429 (/IPI)
P09429 (/IPI)
P09429 (/IPI)
P09429 (/IPI)
P09429 (/IPI)
P09429 (/IPI)
P09429 (/IPI)
P09429 (/IPI)
P09429 (/IPI)
P09429 (/IPI)
(24 more) |
DNA binding, bending GO:0008301
The activity of binding selectively and non-covalently to and distorting the original structure of DNA, typically a straight helix, into a bend, or increasing the bend if the original structure was intrinsically bent due to its sequence.
|
34 |
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
(24 more) |
Lyase activity GO:0016829
Catalysis of the cleavage of C-C, C-O, C-N and other bonds by other means than by hydrolysis or oxidation, or conversely adding a group to a double bond. They differ from other enzymes in that two substrates are involved in one reaction direction, but only one in the other direction. When acting on the single substrate, a molecule is eliminated and this generates either a new double bond or a new ring.
|
34 |
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
(24 more) |
C-X-C chemokine binding GO:0019958
Interacting selectively and non-covalently with a C-X-C chemokine; C-X-C chemokines have a single amino acid between the first two cysteines of the characteristic four cysteine motif.
|
34 |
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
(24 more) |
Chemoattractant activity GO:0042056
Providing the environmental signal that initiates the directed movement of a motile cell or organism towards a higher concentration of that signal.
|
34 |
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
(24 more) |
RAGE receptor binding GO:0050786
Interacting selectively and non-covalently with the RAGE receptor, the receptor for advanced glycation end-products.
|
34 |
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
(24 more) |
DNA polymerase binding GO:0070182
Interacting selectively and non-covalently with a DNA polymerase.
|
34 |
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
(24 more) |
Repressing transcription factor binding GO:0070491
Interacting selectively and non-covalently with a transcription repressor, any protein whose activity is required to prevent or downregulate transcription.
|
34 |
P09429 (/IPI)
P09429 (/IPI)
P09429 (/IPI)
P09429 (/IPI)
P09429 (/IPI)
P09429 (/IPI)
P09429 (/IPI)
P09429 (/IPI)
P09429 (/IPI)
P09429 (/IPI)
(24 more) |
Single-stranded DNA binding GO:0003697
Interacting selectively and non-covalently with single-stranded DNA.
|
26 |
P10103 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
(16 more) |
Chemoattractant activity GO:0042056
Providing the environmental signal that initiates the directed movement of a motile cell or organism towards a higher concentration of that signal.
|
21 |
P10103 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
(11 more) |
Histone binding GO:0042393
Interacting selectively and non-covalently with a histone, any of a group of water-soluble proteins found in association with the DNA of eukaroytic chromosomes. They are involved in the condensation and coiling of chromosomes during cell division and have also been implicated in nonspecific suppression of gene activity.
|
21 |
P10103 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
(11 more) |
DNA binding GO:0003677
Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
|
11 |
P26583 (/IMP)
P26583 (/IMP)
P26583 (/IMP)
P26583 (/IMP)
P26583 (/IMP)
P26583 (/IMP)
P26583 (/IMP)
P26583 (/IMP)
P26583 (/IMP)
P26583 (/IMP)
(1 more) |
RAGE receptor binding GO:0050786
Interacting selectively and non-covalently with the RAGE receptor, the receptor for advanced glycation end-products.
|
11 |
P26583 (/IGI)
P26583 (/IGI)
P26583 (/IGI)
P26583 (/IGI)
P26583 (/IGI)
P26583 (/IGI)
P26583 (/IGI)
P26583 (/IGI)
P26583 (/IGI)
P26583 (/IGI)
(1 more) |
Cytokine activity GO:0005125
Functions to control the survival, growth, differentiation and effector function of tissues and cells.
|
10 | P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) |
Unmethylated CpG binding GO:0045322
Interacting selectively and non-covalently with unmethylated CpG motifs. Unmethylated CpG dinucleotides are often associated with gene promoters.
|
10 | P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) |
RAGE receptor binding GO:0050786
Interacting selectively and non-covalently with the RAGE receptor, the receptor for advanced glycation end-products.
|
10 | P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) |
Four-way junction DNA binding GO:0000400
Interacting selectively and non-covalently with DNA containing four-way junctions, also known as Holliday junctions, a structure where two DNA double strands are held together by reciprocal exchange of two of the four strands, one strand each from the two original helices.
|
9 | F1NPU8 (/IDA) P26584 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) Q9YH06 (/IDA) Q9YH06 (/IDA) |
Transcription factor binding GO:0008134
Interacting selectively and non-covalently with a transcription factor, a protein required to initiate or regulate transcription.
|
7 | P30681 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) Q3U566 (/IDA) |
Open form four-way junction DNA binding GO:0000401
Interacting selectively and non-covalently with DNA containing the open form of a four-way junction, also known as a Holliday junction, a structure where two DNA double strands are held together by reciprocal exchange of two of the four strands, one strand each from the two original helices. The open form of a four-way junction can be diagrammed without any of the strands crossing over.
|
5 | P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) |
Open form four-way junction DNA binding GO:0000401
Interacting selectively and non-covalently with DNA containing the open form of a four-way junction, also known as a Holliday junction, a structure where two DNA double strands are held together by reciprocal exchange of two of the four strands, one strand each from the two original helices. The open form of a four-way junction can be diagrammed without any of the strands crossing over.
|
5 | P63158 (/ISO) P63158 (/ISO) P63158 (/ISO) P63158 (/ISO) P63158 (/ISO) |
Crossed form four-way junction DNA binding GO:0000402
Interacting selectively and non-covalently with DNA containing the crossed form of a four-way junction, also known as a Holliday junction, a structure where two DNA double strands are held together by reciprocal exchange of two of the four strands, one strand each from the two original helices. The crossed form of a four-way junction cannot be diagrammed without any of the strands crossing over, and instead contains a single crossover between two of the strands.
|
5 | P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) |
Crossed form four-way junction DNA binding GO:0000402
Interacting selectively and non-covalently with DNA containing the crossed form of a four-way junction, also known as a Holliday junction, a structure where two DNA double strands are held together by reciprocal exchange of two of the four strands, one strand each from the two original helices. The crossed form of a four-way junction cannot be diagrammed without any of the strands crossing over, and instead contains a single crossover between two of the strands.
|
5 | P63158 (/ISO) P63158 (/ISO) P63158 (/ISO) P63158 (/ISO) P63158 (/ISO) |
Phosphatidylserine binding GO:0001786
Interacting selectively and non-covalently with phosphatidylserine, a class of glycophospholipids in which a phosphatidyl group is esterified to the hydroxyl group of L-serine.
|
5 | P63158 (/TAS) P63158 (/TAS) P63158 (/TAS) P63158 (/TAS) P63158 (/TAS) |
Bent DNA binding GO:0003681
Interacting selectively and non-covalently with DNA in a bent conformation.
|
5 | P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) |
Bent DNA binding GO:0003681
Interacting selectively and non-covalently with DNA in a bent conformation.
|
5 | P63158 (/ISO) P63158 (/ISO) P63158 (/ISO) P63158 (/ISO) P63158 (/ISO) |
Double-stranded RNA binding GO:0003725
Interacting selectively and non-covalently with double-stranded RNA.
|
5 | P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) |
Single-stranded RNA binding GO:0003727
Interacting selectively and non-covalently with single-stranded RNA.
|
5 | P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) |
Cytokine activity GO:0005125
Functions to control the survival, growth, differentiation and effector function of tissues and cells.
|
5 | P63158 (/ISO) P63158 (/ISO) P63158 (/ISO) P63158 (/ISO) P63158 (/ISO) |
5S rRNA binding GO:0008097
Interacting selectively and non-covalently with 5S ribosomal RNA, the smallest RNA constituent of a ribosome.
|
5 | P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) |
Heparin binding GO:0008201
Interacting selectively and non-covalently with heparin, any member of a group of glycosaminoglycans found mainly as an intracellular component of mast cells and which consist predominantly of alternating alpha-(1->4)-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues.
|
5 | P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) |
Heparin binding GO:0008201
Interacting selectively and non-covalently with heparin, any member of a group of glycosaminoglycans found mainly as an intracellular component of mast cells and which consist predominantly of alternating alpha-(1->4)-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues.
|
5 | P63159 (/TAS) P63159 (/TAS) P63159 (/TAS) P63159 (/TAS) P63159 (/TAS) |
Calcium-dependent protein kinase regulator activity GO:0010858
Modulates the activity of a calcium-dependent protein kinase, an enzyme which phosphorylates a protein in a calcium-dependent manner.
|
5 | P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) |
Protein kinase activator activity GO:0030295
Binds to and increases the activity of a protein kinase, an enzyme which phosphorylates a protein.
|
5 | P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) |
Peptide binding GO:0042277
Interacting selectively and non-covalently with peptides, any of a group of organic compounds comprising two or more amino acids linked by peptide bonds.
|
5 | P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) |
Protein dimerization activity GO:0046983
The formation of a protein dimer, a macromolecular structure consists of two noncovalently associated identical or nonidentical subunits.
|
5 | P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) |
RAGE receptor binding GO:0050786
Interacting selectively and non-covalently with the RAGE receptor, the receptor for advanced glycation end-products.
|
5 | P63159 (/IMP) P63159 (/IMP) P63159 (/IMP) P63159 (/IMP) P63159 (/IMP) |
RAGE receptor binding GO:0050786
Interacting selectively and non-covalently with the RAGE receptor, the receptor for advanced glycation end-products.
|
5 | P63159 (/IPI) P63159 (/IPI) P63159 (/IPI) P63159 (/IPI) P63159 (/IPI) |
Glycolipid binding GO:0051861
Interacting selectively and non-covalently with a glycolipid, any compound containing one or more monosaccharide residues bound by a glycosidic linkage to a hydrophobic group such as an acylglycerol, a sphingoid, a ceramide (N-acylsphingoid) or a prenyl phosphate.
|
5 | P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) |
Non-sequence-specific DNA binding, bending GO:0044378
The activity of binding selectively and non-covalently to DNA in a sequence-independent manner and distorting the original structure of DNA, typically a straight helix, into a bend, or increasing the bend if the original structure was intrinsically bent due to its sequence.
|
4 | F1RJ01 (/IDA) F2Z594 (/IDA) P12682 (/IDA) P17741 (/IDA) |
Supercoiled DNA binding GO:0097100
Interacting selectively and non-covalently with supercoiled DNA. For example, during replication and transcription, template DNA is negatively supercoiled in the receding downstream DNA and positively supercoiled in the approaching downstream DNA.
|
4 | F1RJ01 (/IDA) P17741 (/IDA) Q9YH06 (/IDA) Q9YH06 (/IDA) |
Bubble DNA binding GO:0000405
Interacting selectively and non-covalently with DNA that contains a bubble. A bubble occurs when DNA contains a region of unpaired, single-stranded DNA flanked on both sides by regions of paired, double-stranded DNA.
|
2 | Q9YH06 (/IDA) Q9YH06 (/IDA) |
Enhancer sequence-specific DNA binding GO:0001158
Interacting selectively and non-covalently with a specific sequence of DNA that is part of an enhancer, a transcription regulatory region that is somewhat distal from the core promoter and which enhances transcription from that promoter.
|
2 | P30681 (/IDA) Q3U566 (/IDA) |
Double-stranded DNA binding GO:0003690
Interacting selectively and non-covalently with double-stranded DNA.
|
2 | F1RJ01 (/IMP) P17741 (/IMP) |
Single-stranded DNA binding GO:0003697
Interacting selectively and non-covalently with single-stranded DNA.
|
2 | F1RJ01 (/IMP) P17741 (/IMP) |
Protein domain specific binding GO:0019904
Interacting selectively and non-covalently with a specific domain of a protein.
|
2 | F1RJ01 (/ISS) P17741 (/ISS) |
DNA binding GO:0003677
Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
|
1 | P17741 (/IDA) |
DNA binding GO:0003677
Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
|
1 | P30681 (/ISO) |
Damaged DNA binding GO:0003684
Interacting selectively and non-covalently with damaged DNA.
|
1 | P30681 (/ISO) |
Double-stranded DNA binding GO:0003690
Interacting selectively and non-covalently with double-stranded DNA.
|
1 | P52925 (/TAS) |
Transcription coactivator activity GO:0003713
A protein or a member of a complex that interacts specifically and non-covalently with a DNA-bound DNA-binding transcription factor to activate the transcription of specific genes. Coactivators often act by altering chromatin structure and modifications. For example, one class of transcription coregulators modifies chromatin structure through covalent modification of histones. A second ATP-dependent class modifies the conformation of chromatin. Another type of coregulator activity is the bridging of a DNA-binding transcription factor to the basal transcription machinery. The Mediator complex, which bridges transcription factors and RNA polymerase, is also a transcription coactivator.
|
1 | P30681 (/ISO) |
Drug binding GO:0008144
Interacting selectively and non-covalently with a drug, any naturally occurring or synthetic substance, other than a nutrient, that, when administered or applied to an organism, affects the structure or functioning of the organism; in particular, any such substance used in the diagnosis, prevention, or treatment of disease.
|
1 | Q3U566 (/IDA) |
Lipid binding GO:0008289
Interacting selectively and non-covalently with a lipid.
|
1 | P52925 (/IDA) |
DNA binding, bending GO:0008301
The activity of binding selectively and non-covalently to and distorting the original structure of DNA, typically a straight helix, into a bend, or increasing the bend if the original structure was intrinsically bent due to its sequence.
|
1 | P30681 (/ISO) |
Protein domain specific binding GO:0019904
Interacting selectively and non-covalently with a specific domain of a protein.
|
1 | P30681 (/IPI) |
Nucleosomal histone binding GO:0031493
Interacting selectively and non-covalently with a histone that is assembled into a nucleosome.
|
1 | P52925 (/IDA) |
Chemoattractant activity GO:0042056
Providing the environmental signal that initiates the directed movement of a motile cell or organism towards a higher concentration of that signal.
|
1 | P30681 (/ISO) |
Transcription regulatory region DNA binding GO:0044212
Interacting selectively and non-covalently with a DNA region that regulates the transcription of a region of DNA, which may be a gene, cistron, or operon. Binding may occur as a sequence specific interaction or as an interaction observed only once a factor has been recruited to the DNA by other factors.
|
1 | P30681 (/ISO) |
RAGE receptor binding GO:0050786
Interacting selectively and non-covalently with the RAGE receptor, the receptor for advanced glycation end-products.
|
1 | P30681 (/ISO) |
There are 209 GO terms relating to "biological process"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
DNA geometric change GO:0032392
The process in which a transformation is induced in the geometry of a DNA double helix, resulting in a change in twist, writhe, or both, but with no change in linking number. Includes the unwinding of double-stranded DNA by helicases.
|
1060 |
A0A024RDR0 (/ISS)
A0A024RDR0 (/ISS)
A0A024RDR0 (/ISS)
A0A024RDR0 (/ISS)
A0A024RDR0 (/ISS)
A0A024RDR0 (/ISS)
A0A024RDR0 (/ISS)
A0A024RDR0 (/ISS)
A0A024RDR0 (/ISS)
A0A024RDR0 (/ISS)
(1050 more) |
DNA ligation involved in DNA repair GO:0051103
The re-formation of a broken phosphodiester bond in the DNA backbone, carried out by DNA ligase, that contributes to DNA repair.
|
655 |
A0A059XNA0 (/ISS)
A0A059XNA0 (/ISS)
A0A059XNA0 (/ISS)
A0A059XNA0 (/ISS)
A0A059XNA0 (/ISS)
A0A059XNA0 (/ISS)
A0A059XNA0 (/ISS)
A0A059XNA0 (/ISS)
A0A059XNA0 (/ISS)
A0A059XNA0 (/ISS)
(645 more) |
Nucleosome assembly GO:0006334
The aggregation, arrangement and bonding together of a nucleosome, the beadlike structural units of eukaryotic chromatin composed of histones and DNA.
|
469 |
A0A059XNA0 (/ISS)
A0A059XNA0 (/ISS)
A0A059XNA0 (/ISS)
A0A059XNA0 (/ISS)
A0A059XNA0 (/ISS)
A0A059XNA0 (/ISS)
A0A059XNA0 (/ISS)
A0A059XNA0 (/ISS)
A0A059XNA0 (/ISS)
A0A059XNA0 (/ISS)
(459 more) |
Inflammatory response to antigenic stimulus GO:0002437
An inflammatory response to an antigenic stimulus, which can be include any number of T cell or B cell epitopes.
|
202 |
A0A087QNV0 (/ISS)
A0A087QNV0 (/ISS)
A0A087QNV0 (/ISS)
A0A087QNV0 (/ISS)
A0A091F7A2 (/ISS)
A0A091GCL3 (/ISS)
A0A091GCL3 (/ISS)
A0A091H0T5 (/ISS)
A0A091IH21 (/ISS)
A0A091KT98 (/ISS)
(192 more) |
Response to lipopolysaccharide GO:0032496
Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
|
202 |
A0A087QNV0 (/ISS)
A0A087QNV0 (/ISS)
A0A087QNV0 (/ISS)
A0A087QNV0 (/ISS)
A0A091F7A2 (/ISS)
A0A091GCL3 (/ISS)
A0A091GCL3 (/ISS)
A0A091H0T5 (/ISS)
A0A091IH21 (/ISS)
A0A091KT98 (/ISS)
(192 more) |
Response to drug GO:0042493
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
|
202 |
A0A087QNV0 (/ISS)
A0A087QNV0 (/ISS)
A0A087QNV0 (/ISS)
A0A087QNV0 (/ISS)
A0A091F7A2 (/ISS)
A0A091GCL3 (/ISS)
A0A091GCL3 (/ISS)
A0A091H0T5 (/ISS)
A0A091IH21 (/ISS)
A0A091KT98 (/ISS)
(192 more) |
Defense response to Gram-negative bacterium GO:0050829
Reactions triggered in response to the presence of a Gram-negative bacterium that act to protect the cell or organism.
|
196 |
A0A060Y547 (/ISS)
A0A087QNV0 (/ISS)
A0A087QNV0 (/ISS)
A0A087QNV0 (/ISS)
A0A087QNV0 (/ISS)
A0A087VBG6 (/ISS)
A0A091F7A2 (/ISS)
A0A091GCL3 (/ISS)
A0A091GCL3 (/ISS)
A0A091H0T5 (/ISS)
(186 more) |
Defense response to Gram-positive bacterium GO:0050830
Reactions triggered in response to the presence of a Gram-positive bacterium that act to protect the cell or organism.
|
191 |
A0A087QNV0 (/ISS)
A0A087QNV0 (/ISS)
A0A087QNV0 (/ISS)
A0A087QNV0 (/ISS)
A0A087VBG6 (/ISS)
A0A091F7A2 (/ISS)
A0A091GCL3 (/ISS)
A0A091GCL3 (/ISS)
A0A091H0T5 (/ISS)
A0A091IH21 (/ISS)
(181 more) |
Regulation of neurogenesis GO:0050767
Any process that modulates the frequency, rate or extent of neurogenesis, the generation of cells in the nervous system.
|
180 |
A0A091GCL3 (/ISS)
A0A091GCL3 (/ISS)
A0A091H0T5 (/ISS)
A0A091KT98 (/ISS)
A0A091KT98 (/ISS)
A0A091PGF7 (/ISS)
A0A091PGF7 (/ISS)
A0A091PGF7 (/ISS)
A0A093RXY1 (/ISS)
A0A093RXY1 (/ISS)
(170 more) |
Regulation of stem cell proliferation GO:0072091
Any process that modulates the frequency, rate or extent of stem cell proliferation. A stem cell is a cell that retains the ability to divide and proliferate throughout life to provide progenitor cells that can differentiate into specialized cells.
|
180 |
A0A091GCL3 (/ISS)
A0A091GCL3 (/ISS)
A0A091H0T5 (/ISS)
A0A091KT98 (/ISS)
A0A091KT98 (/ISS)
A0A091PGF7 (/ISS)
A0A091PGF7 (/ISS)
A0A091PGF7 (/ISS)
A0A093RXY1 (/ISS)
A0A093RXY1 (/ISS)
(170 more) |
DNA topological change GO:0006265
The process in which a transformation is induced in the topological structure of a double-stranded DNA helix, resulting in a change in linking number.
|
176 |
A0A096MR30 (/ISS)
A0A096MR30 (/ISS)
A0A096MR30 (/ISS)
A0A096MR30 (/ISS)
A0A2J8R9D1 (/ISS)
A0A2J8R9D1 (/ISS)
A0A2J8R9D1 (/ISS)
A0A2J8R9D1 (/ISS)
D2GUW1 (/ISS)
D2GUW1 (/ISS)
(166 more) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
169 |
A0A091GCL3 (/ISS)
A0A091GCL3 (/ISS)
A0A091H0T5 (/ISS)
A0A091KT98 (/ISS)
A0A091KT98 (/ISS)
A0A091PGF7 (/ISS)
A0A091PGF7 (/ISS)
A0A091PGF7 (/ISS)
A0A093RXY1 (/ISS)
A0A093RXY1 (/ISS)
(159 more) |
Negative regulation of gene expression GO:0010629
Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
169 |
A0A091GCL3 (/ISS)
A0A091GCL3 (/ISS)
A0A091H0T5 (/ISS)
A0A091KT98 (/ISS)
A0A091KT98 (/ISS)
A0A091PGF7 (/ISS)
A0A091PGF7 (/ISS)
A0A091PGF7 (/ISS)
A0A093RXY1 (/ISS)
A0A093RXY1 (/ISS)
(159 more) |
Regulation of T cell mediated immune response to tumor cell GO:0002840
Any process that modulates the frequency, rate, or extent of a T cell mediated immune response to tumor cell.
|
84 |
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
(74 more) |
Positive regulation of DNA ligation GO:0051106
Any process that activates or increases the frequency, rate or extent of DNA ligation, the re-formation of a broken phosphodiester bond in the DNA backbone, carried out by DNA ligase.
|
84 |
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
(74 more) |
Positive regulation of toll-like receptor 9 signaling pathway GO:0034165
Any process that activates or increases the frequency, rate, or extent of toll-like receptor 9 signaling pathway.
|
79 |
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
(69 more) |
V(D)J recombination GO:0033151
The process in which immune receptor V, D, and J, or V and J gene segments, depending on the specific receptor, are recombined within a single locus utilizing the conserved heptamer and nonomer recombination signal sequences (RSS).
|
55 |
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
(45 more) |
Apoptotic cell clearance GO:0043277
The recognition and removal of an apoptotic cell by a neighboring cell or by a phagocyte.
|
55 |
P10103 (/ISS)
P10103 (/ISS)
P10103 (/ISS)
P10103 (/ISS)
P10103 (/ISS)
P10103 (/ISS)
P10103 (/ISS)
P10103 (/ISS)
P10103 (/ISS)
P10103 (/ISS)
(45 more) |
Neutrophil clearance GO:0097350
The selective elimination of senescent neutrophils from the body by autoregulatory mechanisms.
|
55 |
P10103 (/ISS)
P10103 (/ISS)
P10103 (/ISS)
P10103 (/ISS)
P10103 (/ISS)
P10103 (/ISS)
P10103 (/ISS)
P10103 (/ISS)
P10103 (/ISS)
P10103 (/ISS)
(45 more) |
Regulation of transcription by RNA polymerase II GO:0006357
Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II.
|
46 |
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
(36 more) |
Positive regulation of DNA binding GO:0043388
Any process that increases the frequency, rate or extent of DNA binding. DNA binding is any process in which a gene product interacts selectively with DNA (deoxyribonucleic acid).
|
46 |
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
(36 more) |
Apoptotic DNA fragmentation GO:0006309
The cleavage of DNA during apoptosis, which usually occurs in two stages: cleavage into fragments of about 50 kbp followed by cleavage between nucleosomes to yield 200 bp fragments.
|
45 |
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
(35 more) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
45 |
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
(35 more) |
Tumor necrosis factor secretion GO:1990774
The regulated release of tumor necrosis factor from a cell. Tumor necrosis factor is an inflammatory cytokine produced by macrophages/monocytes during acute inflammation and which is responsible for a diverse range of signaling events within cells, leading to necrosis or apoptosis.
|
44 |
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
(34 more) |
Regulation of autophagy GO:0010506
Any process that modulates the frequency, rate or extent of autophagy. Autophagy is the process in which cells digest parts of their own cytoplasm.
|
39 |
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
(29 more) |
Positive regulation of ERK1 and ERK2 cascade GO:0070374
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
|
39 |
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
(29 more) |
Negative regulation of transcription by RNA polymerase II GO:0000122
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
|
34 |
P09429 (/IGI)
P09429 (/IGI)
P09429 (/IGI)
P09429 (/IGI)
P09429 (/IGI)
P09429 (/IGI)
P09429 (/IGI)
P09429 (/IGI)
P09429 (/IGI)
P09429 (/IGI)
(24 more) |
Negative regulation of transcription by RNA polymerase II GO:0000122
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
|
34 |
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
(24 more) |
Myeloid dendritic cell activation GO:0001773
The change in morphology and behavior of a dendritic cell resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.
|
34 |
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
(24 more) |
Activation of innate immune response GO:0002218
Any process that initiates an innate immune response. Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens. Examples of this process include activation of the hypersensitive response of Arabidopsis thaliana and activation of any NOD or TLR signaling pathway in vertebrate species.
|
34 |
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
(24 more) |
Toll-like receptor signaling pathway GO:0002224
Any series of molecular signals generated as a consequence of binding to a toll-like receptor. Toll-like receptors directly bind pattern motifs from a variety of microbial sources to initiate innate immune response.
|
34 |
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
(24 more) |
Dendritic cell chemotaxis GO:0002407
The movement of a dendritic cell in response to an external stimulus.
|
34 |
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
(24 more) |
Inflammatory response to antigenic stimulus GO:0002437
An inflammatory response to an antigenic stimulus, which can be include any number of T cell or B cell epitopes.
|
34 |
P09429 (/IEP)
P09429 (/IEP)
P09429 (/IEP)
P09429 (/IEP)
P09429 (/IEP)
P09429 (/IEP)
P09429 (/IEP)
P09429 (/IEP)
P09429 (/IEP)
P09429 (/IEP)
(24 more) |
Regulation of tolerance induction GO:0002643
Any process that modulates the frequency, rate, or extent of tolerance induction.
|
34 |
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
(24 more) |
DNA recombination GO:0006310
Any process in which a new genotype is formed by reassortment of genes resulting in gene combinations different from those that were present in the parents. In eukaryotes genetic recombination can occur by chromosome assortment, intrachromosomal recombination, or nonreciprocal interchromosomal recombination. Interchromosomal recombination occurs by crossing over. In bacteria it may occur by genetic transformation, conjugation, transduction, or F-duction.
|
34 |
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
(24 more) |
Chromatin silencing GO:0006342
Repression of transcription by altering the structure of chromatin, e.g. by conversion of large regions of DNA into an inaccessible state often called heterochromatin.
|
34 |
P09429 (/IGI)
P09429 (/IGI)
P09429 (/IGI)
P09429 (/IGI)
P09429 (/IGI)
P09429 (/IGI)
P09429 (/IGI)
P09429 (/IGI)
P09429 (/IGI)
P09429 (/IGI)
(24 more) |
Inflammatory response GO:0006954
The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.
|
34 |
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
(24 more) |
Positive regulation of cytosolic calcium ion concentration GO:0007204
Any process that increases the concentration of calcium ions in the cytosol.
|
34 |
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
(24 more) |
Negative regulation of RNA polymerase II transcriptional preinitiation complex assembly GO:0017055
Any process that stops, prevents, or reduces the frequency, rate or extent of RNA polymerase II transcriptional preinitiation complex assembly.
|
34 |
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
(24 more) |
Neuron projection development GO:0031175
The process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites).
|
34 |
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
(24 more) |
Regulation of restriction endodeoxyribonuclease activity GO:0032072
Any process that modulates the frequency, rate or extent of a restriction endodeoxyribonuclease activity, the catalysis of endonucleolytic cleavage of DNA in a site-specific manner, resulting in double-strand breaks.
|
34 |
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
(24 more) |
Positive regulation of mismatch repair GO:0032425
Any process that activates or increases the frequency, rate or extent of mismatch repair.
|
34 |
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
(24 more) |
Negative regulation of interferon-gamma production GO:0032689
Any process that stops, prevents, or reduces the frequency, rate, or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon.
|
34 |
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
(24 more) |
Positive regulation of interleukin-10 production GO:0032733
Any process that activates or increases the frequency, rate, or extent of interleukin-10 production.
|
34 |
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
(24 more) |
Positive regulation of interleukin-12 production GO:0032735
Any process that activates or increases the frequency, rate, or extent of interleukin-12 production.
|
34 |
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
(24 more) |
T-helper 1 cell activation GO:0035711
The change in morphology and behavior of a T-helper 1 cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.
|
34 |
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
(24 more) |
Positive regulation of activated T cell proliferation GO:0042104
Any process that activates or increases the rate or extent of activated T cell proliferation.
|
34 |
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
(24 more) |
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
|
34 |
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
(24 more) |
Apoptotic cell clearance GO:0043277
The recognition and removal of an apoptotic cell by a neighboring cell or by a phagocyte.
|
34 |
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
(24 more) |
Positive regulation of cysteine-type endopeptidase activity involved in apoptotic process GO:0043280
Any process that activates or increases the activity of a cysteine-type endopeptidase involved in the apoptotic process.
|
34 |
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
(24 more) |
Neutrophil degranulation GO:0043312
The regulated exocytosis of secretory granules containing preformed mediators such as proteases, lipases, and inflammatory mediators by a neutrophil.
|
34 |
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
(24 more) |
Negative regulation of CD4-positive, alpha-beta T cell differentiation GO:0043371
Any process that stops, prevents, or reduces the frequency, rate, or extent of CD4-positive, alpha-beta T cell differentiation.
|
34 |
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
(24 more) |
Positive regulation of MAPK cascade GO:0043410
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the MAPK cascade.
|
34 |
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
(24 more) |
Positive regulation of blood vessel endothelial cell migration GO:0043536
Any process that activates or increases the frequency, rate or extent of the migration of the endothelial cells of blood vessels.
|
34 |
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
(24 more) |
Negative regulation of blood vessel endothelial cell migration GO:0043537
Any process that stops, prevents, or reduces the frequency, rate or extent of the migration of the endothelial cells of blood vessels.
|
34 |
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
(24 more) |
T-helper 1 cell differentiation GO:0045063
The process in which a relatively unspecialized T cell acquires the specialized features of a T-helper 1 (Th1) cell. A Th1 cell is a CD4-positive, alpha-beta T cell that has the phenotype T-bet-positive and produces interferon-gamma.
|
34 |
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
(24 more) |
Innate immune response GO:0045087
Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens.
|
34 |
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
(24 more) |
Positive regulation of JNK cascade GO:0046330
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the JNK cascade.
|
34 |
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
(24 more) |
Positive regulation of interleukin-1 secretion GO:0050716
Any process that activates or increases the frequency, rate or extent of the regulated release of interleukin-1 from a cell.
|
34 |
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
(24 more) |
Cellular response to lipopolysaccharide GO:0071222
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
|
34 |
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
P09429 (/ISS)
(24 more) |
Positive regulation of monocyte chemotaxis GO:0090026
Any process that increases the frequency, rate, or extent of monocyte chemotaxis.
|
34 |
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
(24 more) |
Neutrophil clearance GO:0097350
The selective elimination of senescent neutrophils from the body by autoregulatory mechanisms.
|
34 |
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
(24 more) |
Positive regulation of vascular endothelial cell proliferation GO:1905564
Any process that activates or increases the frequency, rate or extent of vascular endothelial cell proliferation.
|
34 |
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
(24 more) |
Negative regulation of apoptotic cell clearance GO:2000426
Any process that stops, prevents or reduces the frequency, rate or extent of apoptotic cell clearance.
|
34 |
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
(24 more) |
Positive regulation of interleukin-6 secretion GO:2000778
Any process that activates or increases the frequency, rate or extent of interleukin-6 secretion.
|
34 |
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
(24 more) |
Positive regulation of dendritic cell differentiation GO:2001200
Any process that activates or increases the frequency, rate or extent of dendritic cell differentiation.
|
34 |
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
P09429 (/IMP)
(24 more) |
Regulation of transcription by RNA polymerase II GO:0006357
Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II.
|
26 |
F1RJ01 (/ISS)
P10103 (/ISS)
P10103 (/ISS)
P10103 (/ISS)
P10103 (/ISS)
P10103 (/ISS)
P10103 (/ISS)
P10103 (/ISS)
P10103 (/ISS)
P10103 (/ISS)
(16 more) |
DNA topological change GO:0006265
The process in which a transformation is induced in the topological structure of a double-stranded DNA helix, resulting in a change in linking number.
|
23 |
F1RJ01 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
(13 more) |
DNA recombination GO:0006310
Any process in which a new genotype is formed by reassortment of genes resulting in gene combinations different from those that were present in the parents. In eukaryotes genetic recombination can occur by chromosome assortment, intrachromosomal recombination, or nonreciprocal interchromosomal recombination. Interchromosomal recombination occurs by crossing over. In bacteria it may occur by genetic transformation, conjugation, transduction, or F-duction.
|
21 |
P10103 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
P10103 (/IDA)
(11 more) |
Chromatin remodeling GO:0006338
Dynamic structural changes to eukaryotic chromatin occurring throughout the cell division cycle. These changes range from the local changes necessary for transcriptional regulation to global changes necessary for chromosome segregation.
|
21 |
P10103 (/NAS)
P10103 (/NAS)
P10103 (/NAS)
P10103 (/NAS)
P10103 (/NAS)
P10103 (/NAS)
P10103 (/NAS)
P10103 (/NAS)
P10103 (/NAS)
P10103 (/NAS)
(11 more) |
Defense response to Gram-negative bacterium GO:0050829
Reactions triggered in response to the presence of a Gram-negative bacterium that act to protect the cell or organism.
|
15 |
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
(5 more) |
Defense response to Gram-positive bacterium GO:0050830
Reactions triggered in response to the presence of a Gram-positive bacterium that act to protect the cell or organism.
|
14 |
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
(4 more) |
Positive regulation of endothelial cell proliferation GO:0001938
Any process that activates or increases the rate or extent of endothelial cell proliferation.
|
11 |
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
(1 more) |
Chromatin organization GO:0006325
Any process that results in the specification, formation or maintenance of the physical structure of eukaryotic chromatin.
|
11 |
P26583 (/NAS)
P26583 (/NAS)
P26583 (/NAS)
P26583 (/NAS)
P26583 (/NAS)
P26583 (/NAS)
P26583 (/NAS)
P26583 (/NAS)
P26583 (/NAS)
P26583 (/NAS)
(1 more) |
Nucleosome assembly GO:0006334
The aggregation, arrangement and bonding together of a nucleosome, the beadlike structural units of eukaryotic chromatin composed of histones and DNA.
|
11 |
P26583 (/NAS)
P26583 (/NAS)
P26583 (/NAS)
P26583 (/NAS)
P26583 (/NAS)
P26583 (/NAS)
P26583 (/NAS)
P26583 (/NAS)
P26583 (/NAS)
P26583 (/NAS)
(1 more) |
Negative regulation of RNA polymerase II transcriptional preinitiation complex assembly GO:0017055
Any process that stops, prevents, or reduces the frequency, rate or extent of RNA polymerase II transcriptional preinitiation complex assembly.
|
11 |
P10103 (/ISS)
P10103 (/ISS)
P10103 (/ISS)
P10103 (/ISS)
P10103 (/ISS)
P10103 (/ISS)
P10103 (/ISS)
P10103 (/ISS)
P10103 (/ISS)
P10103 (/ISS)
(1 more) |
Positive regulation of nuclease activity GO:0032075
Any process that activates or increases the frequency, rate or extent of nuclease activity, the hydrolysis of ester linkages within nucleic acids.
|
11 |
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
(1 more) |
V(D)J recombination GO:0033151
The process in which immune receptor V, D, and J, or V and J gene segments, depending on the specific receptor, are recombined within a single locus utilizing the conserved heptamer and nonomer recombination signal sequences (RSS).
|
11 |
P26583 (/ISS)
P26583 (/ISS)
P26583 (/ISS)
P26583 (/ISS)
P26583 (/ISS)
P26583 (/ISS)
P26583 (/ISS)
P26583 (/ISS)
P26583 (/ISS)
P26583 (/ISS)
(1 more) |
Positive regulation of erythrocyte differentiation GO:0045648
Any process that activates or increases the frequency, rate or extent of erythrocyte differentiation.
|
11 |
P26583 (/IMP)
P26583 (/IMP)
P26583 (/IMP)
P26583 (/IMP)
P26583 (/IMP)
P26583 (/IMP)
P26583 (/IMP)
P26583 (/IMP)
P26583 (/IMP)
P26583 (/IMP)
(1 more) |
Positive regulation of megakaryocyte differentiation GO:0045654
Any process that activates or increases the frequency, rate or extent of megakaryocyte differentiation.
|
11 |
P26583 (/IMP)
P26583 (/IMP)
P26583 (/IMP)
P26583 (/IMP)
P26583 (/IMP)
P26583 (/IMP)
P26583 (/IMP)
P26583 (/IMP)
P26583 (/IMP)
P26583 (/IMP)
(1 more) |
Negative regulation of transcription, DNA-templated GO:0045892
Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.
|
11 |
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
(1 more) |
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
|
11 |
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
(1 more) |
Cell chemotaxis GO:0060326
The directed movement of a motile cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis).
|
11 |
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
(1 more) |
Cellular response to lipopolysaccharide GO:0071222
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
|
11 |
P26583 (/IEP)
P26583 (/IEP)
P26583 (/IEP)
P26583 (/IEP)
P26583 (/IEP)
P26583 (/IEP)
P26583 (/IEP)
P26583 (/IEP)
P26583 (/IEP)
P26583 (/IEP)
(1 more) |
Myeloid dendritic cell activation GO:0001773
The change in morphology and behavior of a dendritic cell resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.
|
10 | P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) |
Plasmacytoid dendritic cell activation GO:0002270
A change in the morphology or behavior of a plasmacytoid dendritic cell resulting from exposure to an activating factor such as a cellular or soluble ligand.
|
10 | P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) |
B cell proliferation involved in immune response GO:0002322
The expansion of a B cell population by cell division following B cell activation during an immune response.
|
10 | P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) |
Dendritic cell chemotaxis GO:0002407
The movement of a dendritic cell in response to an external stimulus.
|
10 | P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) |
Positive regulation of interleukin-6 production GO:0032755
Any process that activates or increases the frequency, rate, or extent of interleukin-6 production.
|
10 | P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) P63159 (/IMP) P63159 (/IMP) P63159 (/IMP) P63159 (/IMP) P63159 (/IMP) |
Positive regulation of tumor necrosis factor production GO:0032760
Any process that activates or increases the frequency, rate, or extent of tumor necrosis factor production.
|
10 | P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) P63159 (/IMP) P63159 (/IMP) P63159 (/IMP) P63159 (/IMP) P63159 (/IMP) |
Toll-like receptor 9 signaling pathway GO:0034162
Any series of molecular signals generated as a consequence of binding to toll-like receptor 9.
|
10 | P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) |
Toll-like receptor 9 signaling pathway GO:0034162
Any series of molecular signals generated as a consequence of binding to toll-like receptor 9.
|
10 | P10103 (/IMP) P10103 (/IMP) P10103 (/IMP) P10103 (/IMP) P10103 (/IMP) P10103 (/IMP) P10103 (/IMP) P10103 (/IMP) P10103 (/IMP) P10103 (/IMP) |
Positive regulation of toll-like receptor 9 signaling pathway GO:0034165
Any process that activates or increases the frequency, rate, or extent of toll-like receptor 9 signaling pathway.
|
10 | P10103 (/IMP) P10103 (/IMP) P10103 (/IMP) P10103 (/IMP) P10103 (/IMP) P10103 (/IMP) P10103 (/IMP) P10103 (/IMP) P10103 (/IMP) P10103 (/IMP) |
Positive regulation of interferon-alpha secretion GO:1902741
Any process that activates or increases the frequency, rate or extent of interferon-alpha secretion.
|
10 | P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) P10103 (/IDA) |
DNA geometric change GO:0032392
The process in which a transformation is induced in the geometry of a DNA double helix, resulting in a change in twist, writhe, or both, but with no change in linking number. Includes the unwinding of double-stranded DNA by helicases.
|
9 | F1NPU8 (/IDA) P26584 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) Q9YH06 (/IDA) Q9YH06 (/IDA) |
Positive regulation of interferon-beta production GO:0032728
Any process that activates or increases the frequency, rate, or extent of interferon-beta production.
|
6 | P30681 (/IMP) P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) |
Positive regulation of innate immune response GO:0045089
Any process that activates or increases the frequency, rate or extent of the innate immune response, the organism's first line of defense against infection.
|
6 | P30681 (/IMP) P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
6 | P30681 (/IMP) P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) |
Positive regulation of NIK/NF-kappaB signaling GO:1901224
Any process that activates or increases the frequency, rate or extent of NIK/NF-kappaB signaling.
|
6 | P12682 (/IDA) P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) |
Cell morphogenesis GO:0000902
The developmental process in which the size or shape of a cell is generated and organized.
|
5 | P63159 (/IMP) P63159 (/IMP) P63159 (/IMP) P63159 (/IMP) P63159 (/IMP) |
Eye development GO:0001654
The process whose specific outcome is the progression of the eye over time, from its formation to the mature structure. The eye is the organ of sight.
|
5 | P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) |
Myeloid dendritic cell activation GO:0001773
The change in morphology and behavior of a dendritic cell resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.
|
5 | P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) |
Positive regulation of protein phosphorylation GO:0001934
Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein.
|
5 | P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) |
Endothelial cell proliferation GO:0001935
The multiplication or reproduction of endothelial cells, resulting in the expansion of a cell population. Endothelial cells are thin flattened cells which line the inside surfaces of body cavities, blood vessels, and lymph vessels, making up the endothelium.
|
5 | P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) |
Positive regulation of mesenchymal cell proliferation GO:0002053
The process of activating or increasing the rate or extent of mesenchymal cell proliferation. Mesenchymal cells are loosely organized embryonic cells.
|
5 | P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) |
Positive regulation of mesenchymal cell proliferation GO:0002053
The process of activating or increasing the rate or extent of mesenchymal cell proliferation. Mesenchymal cells are loosely organized embryonic cells.
|
5 | P63158 (/ISO) P63158 (/ISO) P63158 (/ISO) P63158 (/ISO) P63158 (/ISO) |
Plasmacytoid dendritic cell activation GO:0002270
A change in the morphology or behavior of a plasmacytoid dendritic cell resulting from exposure to an activating factor such as a cellular or soluble ligand.
|
5 | P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) |
Macrophage activation involved in immune response GO:0002281
A change in morphology and behavior of a macrophage resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor, leading to the initiation or perpetuation of an immune response.
|
5 | P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) |
Regulation of tolerance induction GO:0002643
Any process that modulates the frequency, rate, or extent of tolerance induction.
|
5 | P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) |
Regulation of T cell mediated immune response to tumor cell GO:0002840
Any process that modulates the frequency, rate, or extent of a T cell mediated immune response to tumor cell.
|
5 | P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) |
Base-excision repair GO:0006284
In base excision repair, an altered base is removed by a DNA glycosylase enzyme, followed by excision of the resulting sugar phosphate. The small gap left in the DNA helix is filled in by the sequential action of DNA polymerase and DNA ligase.
|
5 | P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) |
Chemotaxis GO:0006935
The directed movement of a motile cell or organism, or the directed growth of a cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis).
|
5 | P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) |
Inflammatory response GO:0006954
The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.
|
5 | P63158 (/TAS) P63158 (/TAS) P63158 (/TAS) P63158 (/TAS) P63158 (/TAS) |
Nervous system development GO:0007399
The process whose specific outcome is the progression of nervous tissue over time, from its formation to its mature state.
|
5 | P63159 (/IMP) P63159 (/IMP) P63159 (/IMP) P63159 (/IMP) P63159 (/IMP) |
Circadian rhythm GO:0007623
Any biological process in an organism that recurs with a regularity of approximately 24 hours.
|
5 | P63159 (/IEP) P63159 (/IEP) P63159 (/IEP) P63159 (/IEP) P63159 (/IEP) |
Negative regulation of DNA replication GO:0008156
Any process that stops, prevents, or reduces the frequency, rate or extent of DNA replication.
|
5 | P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) |
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
|
5 | P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) |
Response to heat GO:0009408
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a heat stimulus, a temperature stimulus above the optimal temperature for that organism.
|
5 | P63159 (/IEP) P63159 (/IEP) P63159 (/IEP) P63159 (/IEP) P63159 (/IEP) |
Response to glucose GO:0009749
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucose stimulus.
|
5 | P63159 (/IEP) P63159 (/IEP) P63159 (/IEP) P63159 (/IEP) P63159 (/IEP) |
Positive regulation of autophagy GO:0010508
Any process that activates, maintains or increases the rate of autophagy. Autophagy is the process in which cells digest parts of their own cytoplasm.
|
5 | P63159 (/IMP) P63159 (/IMP) P63159 (/IMP) P63159 (/IMP) P63159 (/IMP) |
Positive regulation of cell death GO:0010942
Any process that increases the rate or frequency of cell death. Cell death is the specific activation or halting of processes within a cell so that its vital functions markedly cease, rather than simply deteriorating gradually over time, which culminates in cell death.
|
5 | P63159 (/IMP) P63159 (/IMP) P63159 (/IMP) P63159 (/IMP) P63159 (/IMP) |
Positive regulation of neuron projection development GO:0010976
Any process that increases the rate, frequency or extent of neuron projection development. Neuron projection development is the process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites).
|
5 | P63159 (/IMP) P63159 (/IMP) P63159 (/IMP) P63159 (/IMP) P63159 (/IMP) |
Positive regulation of smooth muscle cell migration GO:0014911
Any process that activates, maintains or increases the frequency, rate or extent of smooth muscle cell migration.
|
5 | P63159 (/IMP) P63159 (/IMP) P63159 (/IMP) P63159 (/IMP) P63159 (/IMP) |
Lung development GO:0030324
The process whose specific outcome is the progression of the lung over time, from its formation to the mature structure. In all air-breathing vertebrates the lungs are developed from the ventral wall of the oesophagus as a pouch which divides into two sacs. In amphibians and many reptiles the lungs retain very nearly this primitive sac-like character, but in the higher forms the connection with the esophagus becomes elongated into the windpipe and the inner walls of the sacs become more and more divided, until, in the mammals, the air spaces become minutely divided into tubes ending in small air cells, in the walls of which the blood circulates in a fine network of capillaries. In mammals the lungs are more or less divided into lobes, and each lung occupies a separate cavity in the thorax.
|
5 | P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) |
Positive regulation of cell migration GO:0030335
Any process that activates or increases the frequency, rate or extent of cell migration.
|
5 | P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) |
Positive regulation of cell migration GO:0030335
Any process that activates or increases the frequency, rate or extent of cell migration.
|
5 | P63158 (/ISO) P63158 (/ISO) P63158 (/ISO) P63158 (/ISO) P63158 (/ISO) |
Neuron projection development GO:0031175
The process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites).
|
5 | P63159 (/IGI) P63159 (/IGI) P63159 (/IGI) P63159 (/IGI) P63159 (/IGI) |
Chromatin assembly GO:0031497
The assembly of DNA, histone proteins, other associated proteins, and sometimes RNA, into chromatin structure, beginning with the formation of the basic unit, the nucleosome, followed by organization of the nucleosomes into higher order structures, ultimately giving rise to a complex organization of specific domains within the nucleus.
|
5 | P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) |
Actin cytoskeleton reorganization GO:0031532
A process that is carried out at the cellular level which results in dynamic structural changes to the arrangement of constituent parts of cytoskeletal structures comprising actin filaments and their associated proteins.
|
5 | P63159 (/IMP) P63159 (/IMP) P63159 (/IMP) P63159 (/IMP) P63159 (/IMP) |
DNA geometric change GO:0032392
The process in which a transformation is induced in the geometry of a DNA double helix, resulting in a change in twist, writhe, or both, but with no change in linking number. Includes the unwinding of double-stranded DNA by helicases.
|
5 | P63158 (/ISO) P63158 (/ISO) P63158 (/ISO) P63158 (/ISO) P63158 (/ISO) |
Response to lipopolysaccharide GO:0032496
Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
|
5 | P63159 (/IEP) P63159 (/IEP) P63159 (/IEP) P63159 (/IEP) P63159 (/IEP) |
Positive regulation of interferon-alpha production GO:0032727
Any process that activates or increases the frequency, rate, or extent of interferon-alpha production.
|
5 | P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) |
Positive regulation of interleukin-1 production GO:0032732
Any process that activates or increases the frequency, rate, or extent of interleukin-1 production.
|
5 | P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) |
Positive regulation of interleukin-6 production GO:0032755
Any process that activates or increases the frequency, rate, or extent of interleukin-6 production.
|
5 | P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) |
Positive regulation of interleukin-8 production GO:0032757
Any process that activates or increases the frequency, rate, or extent of interleukin-8 production.
|
5 | P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) |
Positive regulation of tumor necrosis factor production GO:0032760
Any process that activates or increases the frequency, rate, or extent of tumor necrosis factor production.
|
5 | P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) |
Response to insulin GO:0032868
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin stimulus. Insulin is a polypeptide hormone produced by the islets of Langerhans of the pancreas in mammals, and by the homologous organs of other organisms.
|
5 | P63159 (/IEP) P63159 (/IEP) P63159 (/IEP) P63159 (/IEP) P63159 (/IEP) |
Positive regulation of myeloid cell apoptotic process GO:0033034
Any process that activates or increases the frequency, rate, or extent of myeloid cell apoptotic process.
|
5 | P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) |
Positive regulation of toll-like receptor 2 signaling pathway GO:0034137
Any process that activates or increases the frequency, rate, or extent of toll-like receptor 2 signaling pathway.
|
5 | P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) |
Positive regulation of toll-like receptor 4 signaling pathway GO:0034145
Any process that activates or increases the frequency, rate, or extent of toll-like receptor 4 signaling pathway.
|
5 | P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) |
Response to interferon-gamma GO:0034341
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interferon-gamma stimulus. Interferon-gamma is also known as type II interferon.
|
5 | P63159 (/IMP) P63159 (/IMP) P63159 (/IMP) P63159 (/IMP) P63159 (/IMP) |
Endothelial cell chemotaxis GO:0035767
The directed movement of an endothelial cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis).
|
5 | P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) |
Response to drug GO:0042493
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
|
5 | P63159 (/IEP) P63159 (/IEP) P63159 (/IEP) P63159 (/IEP) P63159 (/IEP) |
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
|
5 | P63159 (/IMP) P63159 (/IMP) P63159 (/IMP) P63159 (/IMP) P63159 (/IMP) |
Positive regulation of myeloid cell differentiation GO:0045639
Any process that activates or increases the frequency, rate or extent of myeloid cell differentiation.
|
5 | P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) |
Positive regulation of myoblast differentiation GO:0045663
Any process that activates or increases the frequency, rate or extent of myoblast differentiation. A myoblast is a mononucleate cell type that, by fusion with other myoblasts, gives rise to the myotubes that eventually develop into skeletal muscle fibers.
|
5 | P63159 (/IMP) P63159 (/IMP) P63159 (/IMP) P63159 (/IMP) P63159 (/IMP) |
Positive regulation of glycogen catabolic process GO:0045819
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of glycogen.
|
5 | P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) |
Positive regulation of mitotic cell cycle GO:0045931
Any process that activates or increases the rate or extent of progression through the mitotic cell cycle.
|
5 | P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) |
Positive regulation of mitotic cell cycle GO:0045931
Any process that activates or increases the rate or extent of progression through the mitotic cell cycle.
|
5 | P63158 (/ISO) P63158 (/ISO) P63158 (/ISO) P63158 (/ISO) P63158 (/ISO) |
Positive regulation of interleukin-1 beta secretion GO:0050718
Any process that activates or increases the frequency, rate or extent of the regulated release of interleukin-1 beta from a cell.
|
5 | P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) |
Regulation of inflammatory response GO:0050727
Any process that modulates the frequency, rate or extent of the inflammatory response, the immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents.
|
5 | P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) |
Male-specific defense response to bacterium GO:0050831
A set of reactions, specific to males, that are triggered in response to the presence of a bacterium that act to protect the cell or organism.
|
5 | P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) |
Induction of positive chemotaxis GO:0050930
Any process that initiates the directed movement of a motile cell or organism towards a higher concentration in a concentration gradient of a specific chemical.
|
5 | P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) |
Induction of positive chemotaxis GO:0050930
Any process that initiates the directed movement of a motile cell or organism towards a higher concentration in a concentration gradient of a specific chemical.
|
5 | P63158 (/ISO) P63158 (/ISO) P63158 (/ISO) P63158 (/ISO) P63158 (/ISO) |
Positive regulation of DNA ligation GO:0051106
Any process that activates or increases the frequency, rate or extent of DNA ligation, the re-formation of a broken phosphodiester bond in the DNA backbone, carried out by DNA ligase.
|
5 | P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) |
Response to glucocorticoid GO:0051384
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucocorticoid stimulus. Glucocorticoids are hormonal C21 corticosteroids synthesized from cholesterol with the ability to bind with the cortisol receptor and trigger similar effects. Glucocorticoids act primarily on carbohydrate and protein metabolism, and have anti-inflammatory effects.
|
5 | P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) |
Myoblast proliferation GO:0051450
The multiplication or reproduction of myoblasts, resulting in the expansion of a myoblast cell population. A myoblast is a mononucleate cell type that, by fusion with other myoblasts, gives rise to the myotubes that eventually develop into skeletal muscle fibers.
|
5 | P63159 (/IMP) P63159 (/IMP) P63159 (/IMP) P63159 (/IMP) P63159 (/IMP) |
Cellular response to lipopolysaccharide GO:0071222
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
|
5 | P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) |
Cellular response to interleukin-1 GO:0071347
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-1 stimulus.
|
5 | P63159 (/IEP) P63159 (/IEP) P63159 (/IEP) P63159 (/IEP) P63159 (/IEP) |
Positive regulation of monocyte chemotactic protein-1 production GO:0071639
Any process that activates or increases the frequency, rate, or extent of production of monocyte chemotactic protein-1.
|
5 | P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) |
Positive regulation of macrophage inflammatory protein 1 alpha production GO:0071642
Any process that activates or increases the frequency, rate, or extent of production of macrophage inflammatory protein 1 alpha.
|
5 | P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) |
Positive regulation of wound healing GO:0090303
Any process that increases the rate, frequency, or extent of the series of events that restore integrity to a damaged tissue, following an injury.
|
5 | P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) |
Cellular response to interleukin-7 GO:0098761
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-7 stimulus.
|
5 | P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) |
Positive regulation of sprouting angiogenesis GO:1903672
Any process that activates or increases the frequency, rate or extent of sprouting angiogenesis.
|
5 | P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) |
Regulation of nucleotide-excision repair GO:2000819
Any process that modulates the frequency, rate or extent of nucleotide-excision repair.
|
5 | P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) P63158 (/IMP) |
Nucleosome assembly GO:0006334
The aggregation, arrangement and bonding together of a nucleosome, the beadlike structural units of eukaryotic chromatin composed of histones and DNA.
|
4 | F1RJ01 (/IDA) F2Z594 (/IDA) P12682 (/IDA) P17741 (/IDA) |
DNA ligation involved in DNA repair GO:0051103
The re-formation of a broken phosphodiester bond in the DNA backbone, carried out by DNA ligase, that contributes to DNA repair.
|
4 | F1RJ01 (/IDA) F2Z594 (/IDA) P12682 (/IDA) P17741 (/IDA) |
Inflammatory response to antigenic stimulus GO:0002437
An inflammatory response to an antigenic stimulus, which can be include any number of T cell or B cell epitopes.
|
2 | P30681 (/IMP) Q3U566 (/IMP) |
Spermatogenesis GO:0007283
The process of formation of spermatozoa, including spermatocytogenesis and spermiogenesis.
|
2 | F1RJ01 (/ISS) P17741 (/ISS) |
Spermatid nucleus differentiation GO:0007289
The specialization of the spermatid nucleus during the development of a spermatid into a mature male gamete competent for fertilization.
|
2 | F1RJ01 (/ISS) P17741 (/ISS) |
Male gonad development GO:0008584
The process whose specific outcome is the progression of the male gonad over time, from its formation to the mature structure.
|
2 | F1RJ01 (/ISS) P17741 (/ISS) |
Response to cold GO:0009409
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cold stimulus, a temperature stimulus below the optimal temperature for that organism.
|
2 | Q6NX86 (/IDA) Q7ZVC6 (/IDA) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
2 | P30681 (/IDA) Q3U566 (/IDA) |
Negative regulation of gene expression GO:0010629
Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
2 | P30681 (/IDA) Q3U566 (/IDA) |
Forebrain development GO:0030900
The process whose specific outcome is the progression of the forebrain over time, from its formation to the mature structure. The forebrain is the anterior of the three primary divisions of the developing chordate brain or the corresponding part of the adult brain (in vertebrates, includes especially the cerebral hemispheres, the thalamus, and the hypothalamus and especially in higher vertebrates is the main control center for sensory and associative information processing, visceral functions, and voluntary motor functions).
|
2 | Q6NX86 (/IMP) Q7ZVC6 (/IMP) |
Regeneration GO:0031099
The regrowth of a lost or destroyed body part, such as an organ or tissue. This process may occur via renewal, repair, and/or growth alone (i.e. increase in size or mass).
|
2 | Q6NX86 (/IMP) Q7ZVC6 (/IMP) |
Axon regeneration GO:0031103
The regrowth of axons following their loss or damage.
|
2 | Q6NX86 (/IMP) Q7ZVC6 (/IMP) |
Response to lipopolysaccharide GO:0032496
Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
|
2 | P30681 (/IMP) Q3U566 (/IMP) |
Positive regulation of DNA binding GO:0043388
Any process that increases the frequency, rate or extent of DNA binding. DNA binding is any process in which a gene product interacts selectively with DNA (deoxyribonucleic acid).
|
2 | F1RJ01 (/ISS) P17741 (/ISS) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
2 | F1RJ01 (/ISS) P17741 (/ISS) |
Response to steroid hormone GO:0048545
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a steroid hormone stimulus.
|
2 | F1RJ01 (/ISS) P17741 (/ISS) |
Regulation of neurogenesis GO:0050767
Any process that modulates the frequency, rate or extent of neurogenesis, the generation of cells in the nervous system.
|
2 | P30681 (/IMP) Q3U566 (/IMP) |
Regulation of stem cell proliferation GO:0072091
Any process that modulates the frequency, rate or extent of stem cell proliferation. A stem cell is a cell that retains the ability to divide and proliferate throughout life to provide progenitor cells that can differentiate into specialized cells.
|
2 | P30681 (/IMP) Q3U566 (/IMP) |
Negative regulation of extrinsic apoptotic signaling pathway via death domain receptors GO:1902042
Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway via death domain receptors.
|
2 | F1RJ01 (/ISS) P17741 (/ISS) |
Positive regulation of endothelial cell proliferation GO:0001938
Any process that activates or increases the rate or extent of endothelial cell proliferation.
|
1 | P30681 (/ISO) |
MyD88-dependent toll-like receptor signaling pathway GO:0002755
Any series of molecular signals generated as a consequence of binding to a toll-like receptor where the MyD88 adaptor molecule mediates transduction of the signal. Toll-like receptors directly bind pattern motifs from a variety of microbial sources to initiate innate immune response.
|
1 | P12682 (/IDA) |
Regulation of transcription by RNA polymerase II GO:0006357
Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II.
|
1 | P30681 (/ISO) |
Spermatogenesis GO:0007283
The process of formation of spermatozoa, including spermatocytogenesis and spermiogenesis.
|
1 | P30681 (/IMP) |
Spermatid nucleus differentiation GO:0007289
The specialization of the spermatid nucleus during the development of a spermatid into a mature male gamete competent for fertilization.
|
1 | P30681 (/IMP) |
Nervous system development GO:0007399
The process whose specific outcome is the progression of nervous tissue over time, from its formation to its mature state.
|
1 | P52925 (/IDA) |
Male gonad development GO:0008584
The process whose specific outcome is the progression of the male gonad over time, from its formation to the mature structure.
|
1 | P30681 (/IMP) |
Animal organ regeneration GO:0031100
The regrowth of a lost or destroyed animal organ.
|
1 | P52925 (/IEP) |
Positive regulation of nuclease activity GO:0032075
Any process that activates or increases the frequency, rate or extent of nuclease activity, the hydrolysis of ester linkages within nucleic acids.
|
1 | P30681 (/ISO) |
Toll-like receptor 2 signaling pathway GO:0034134
Any series of molecular signals generated as a consequence of binding to toll-like receptor 2.
|
1 | P12682 (/IDA) |
Toll-like receptor 4 signaling pathway GO:0034142
Any series of molecular signals generated as a consequence of binding to toll-like receptor 4.
|
1 | P12682 (/IDA) |
Response to drug GO:0042493
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
|
1 | Q3U566 (/IDA) |
Positive regulation of DNA binding GO:0043388
Any process that increases the frequency, rate or extent of DNA binding. DNA binding is any process in which a gene product interacts selectively with DNA (deoxyribonucleic acid).
|
1 | P30681 (/ISO) |
Positive regulation of erythrocyte differentiation GO:0045648
Any process that activates or increases the frequency, rate or extent of erythrocyte differentiation.
|
1 | P30681 (/ISO) |
Positive regulation of megakaryocyte differentiation GO:0045654
Any process that activates or increases the frequency, rate or extent of megakaryocyte differentiation.
|
1 | P30681 (/ISO) |
Negative regulation of transcription, DNA-templated GO:0045892
Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.
|
1 | P30681 (/ISO) |
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
|
1 | P52925 (/IMP) |
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
|
1 | P30681 (/ISO) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
1 | P30681 (/ISO) |
Response to steroid hormone GO:0048545
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a steroid hormone stimulus.
|
1 | P30681 (/IMP) |
Defense response to Gram-negative bacterium GO:0050829
Reactions triggered in response to the presence of a Gram-negative bacterium that act to protect the cell or organism.
|
1 | P30681 (/ISO) |
Defense response to Gram-positive bacterium GO:0050830
Reactions triggered in response to the presence of a Gram-positive bacterium that act to protect the cell or organism.
|
1 | P30681 (/ISO) |
Positive regulation of DNA metabolic process GO:0051054
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving DNA.
|
1 | P52925 (/IMP) |
Cell chemotaxis GO:0060326
The directed movement of a motile cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis).
|
1 | P30681 (/ISO) |
Negative regulation of extrinsic apoptotic signaling pathway via death domain receptors GO:1902042
Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway via death domain receptors.
|
1 | P30681 (/IMP) |
There are 37 GO terms relating to "cellular component"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Cell GO:0005623
The basic structural and functional unit of all organisms. Includes the plasma membrane and any external encapsulating structures such as the cell wall and cell envelope.
|
612 |
A0A059XNA0 (/ISS)
A0A059XNA0 (/ISS)
A0A059XNA0 (/ISS)
A0A059XNA0 (/ISS)
A0A059XNA0 (/ISS)
A0A059XNA0 (/ISS)
A0A059XNA0 (/ISS)
A0A059XNA0 (/ISS)
A0A059XNA0 (/ISS)
A0A059XNA0 (/ISS)
(602 more) |
Nuclear chromatin GO:0000790
The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome in the nucleus.
|
538 |
A0A059XNA0 (/ISS)
A0A059XNA0 (/ISS)
A0A059XNA0 (/ISS)
A0A059XNA0 (/ISS)
A0A059XNA0 (/ISS)
A0A059XNA0 (/ISS)
A0A059XNA0 (/ISS)
A0A059XNA0 (/ISS)
A0A059XNA0 (/ISS)
A0A059XNA0 (/ISS)
(528 more) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
225 |
A0A087QNV0 (/ISS)
A0A087QNV0 (/ISS)
A0A087QNV0 (/ISS)
A0A087QNV0 (/ISS)
A0A091F7A2 (/ISS)
A0A091GCL3 (/ISS)
A0A091GCL3 (/ISS)
A0A091H0T5 (/ISS)
A0A091IH21 (/ISS)
A0A091KT98 (/ISS)
(215 more) |
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
225 |
A0A087QNV0 (/ISS)
A0A087QNV0 (/ISS)
A0A087QNV0 (/ISS)
A0A087QNV0 (/ISS)
A0A091F7A2 (/ISS)
A0A091GCL3 (/ISS)
A0A091GCL3 (/ISS)
A0A091H0T5 (/ISS)
A0A091IH21 (/ISS)
A0A091KT98 (/ISS)
(215 more) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
192 |
A0A087QNV0 (/ISS)
A0A087QNV0 (/ISS)
A0A087QNV0 (/ISS)
A0A087QNV0 (/ISS)
A0A091F7A2 (/ISS)
A0A091GCL3 (/ISS)
A0A091GCL3 (/ISS)
A0A091H0T5 (/ISS)
A0A091IH21 (/ISS)
A0A091KT98 (/ISS)
(182 more) |
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
58 |
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
(48 more) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
57 |
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
(47 more) |
Condensed chromosome GO:0000793
A highly compacted molecule of DNA and associated proteins resulting in a cytologically distinct structure.
|
45 |
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
(35 more) |
Nucleoplasm GO:0005654
That part of the nuclear content other than the chromosomes or the nucleolus.
|
45 |
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
(35 more) |
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
|
39 |
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
(29 more) |
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
|
34 |
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
(24 more) |
Transcriptional repressor complex GO:0017053
A protein complex that possesses activity that prevents or downregulates transcription.
|
34 |
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
(24 more) |
Secretory granule lumen GO:0034774
The volume enclosed by the membrane of a secretory granule.
|
34 |
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
(24 more) |
Alphav-beta3 integrin-HMGB1 complex GO:0035868
A protein complex that consists of an alphav-beta3 integrin complex bound to high mobility group box 1 protein.
|
34 |
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
P09429 (/IDA)
(24 more) |
Ficolin-1-rich granule lumen GO:1904813
Any membrane-enclosed lumen that is part of a ficolin-1-rich granule.
|
34 |
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
P09429 (/TAS)
(24 more) |
Condensed chromosome GO:0000793
A highly compacted molecule of DNA and associated proteins resulting in a cytologically distinct structure.
|
26 |
P10103 (/ISS)
P10103 (/ISS)
P10103 (/ISS)
P10103 (/ISS)
P10103 (/ISS)
P10103 (/ISS)
P10103 (/ISS)
P10103 (/ISS)
P10103 (/ISS)
P10103 (/ISS)
(16 more) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
23 |
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
(13 more) |
Perinuclear region of cytoplasm GO:0048471
Cytoplasm situated near, or occurring around, the nucleus.
|
16 |
F1RJ01 (/ISS)
P17741 (/ISS)
P26584 (/ISS)
P30681 (/ISS)
P40673 (/ISS)
P40673 (/ISS)
P40673 (/ISS)
P40673 (/ISS)
P40673 (/ISS)
P40673 (/ISS)
(6 more) |
Cell GO:0005623
The basic structural and functional unit of all organisms. Includes the plasma membrane and any external encapsulating structures such as the cell wall and cell envelope.
|
15 |
F1RJ01 (/IDA)
F2Z594 (/IDA)
P12682 (/IDA)
P17741 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
(5 more) |
Nucleolus GO:0005730
A small, dense body one or more of which are present in the nucleus of eukaryotic cells. It is rich in RNA and protein, is not bounded by a limiting membrane, and is not seen during mitosis. Its prime function is the transcription of the nucleolar DNA into 45S ribosomal-precursor RNA, the processing of this RNA into 5.8S, 18S, and 28S components of ribosomal RNA, and the association of these components with 5S RNA and proteins synthesized outside the nucleolus. This association results in the formation of ribonucleoprotein precursors; these pass into the cytoplasm and mature into the 40S and 60S subunits of the ribosome.
|
11 |
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
(1 more) |
Protein-containing complex GO:0032991
A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which at least one component is a protein and the constituent parts function together.
|
11 |
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
(1 more) |
Perinuclear region of cytoplasm GO:0048471
Cytoplasm situated near, or occurring around, the nucleus.
|
11 |
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
P26583 (/IDA)
(1 more) |
Nuclear chromatin GO:0000790
The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome in the nucleus.
|
7 | F1RJ01 (/IDA) F2Z594 (/IDA) P07746 (/IDA) P12682 (/IDA) P17741 (/IDA) P30681 (/IDA) Q3U566 (/IDA) |
Early endosome GO:0005769
A membrane-bounded organelle that receives incoming material from primary endocytic vesicles that have been generated by clathrin-dependent and clathrin-independent endocytosis; vesicles fuse with the early endosome to deliver cargo for sorting into recycling or degradation pathways.
|
5 | P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
5 | P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) |
Neuron projection GO:0043005
A prolongation or process extending from a nerve cell, e.g. an axon or dendrite.
|
5 | P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) P63158 (/IDA) |
Membrane raft GO:0045121
Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions.
|
5 | P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) P63159 (/IDA) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
2 | Q6NX86 (/IDA) Q7ZVC6 (/IDA) |
Condensed chromosome GO:0000793
A highly compacted molecule of DNA and associated proteins resulting in a cytologically distinct structure.
|
1 | P30681 (/ISO) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
1 | P30681 (/ISO) |
Cell GO:0005623
The basic structural and functional unit of all organisms. Includes the plasma membrane and any external encapsulating structures such as the cell wall and cell envelope.
|
1 | P30681 (/ISO) |
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
1 | P30681 (/IC) |
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
1 | P30681 (/ISO) |
Nucleolus GO:0005730
A small, dense body one or more of which are present in the nucleus of eukaryotic cells. It is rich in RNA and protein, is not bounded by a limiting membrane, and is not seen during mitosis. Its prime function is the transcription of the nucleolar DNA into 45S ribosomal-precursor RNA, the processing of this RNA into 5.8S, 18S, and 28S components of ribosomal RNA, and the association of these components with 5S RNA and proteins synthesized outside the nucleolus. This association results in the formation of ribonucleoprotein precursors; these pass into the cytoplasm and mature into the 40S and 60S subunits of the ribosome.
|
1 | P30681 (/ISO) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
1 | P30681 (/ISO) |
Protein-containing complex GO:0032991
A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which at least one component is a protein and the constituent parts function together.
|
1 | P30681 (/ISO) |
Perinuclear region of cytoplasm GO:0048471
Cytoplasm situated near, or occurring around, the nucleus.
|
1 | P30681 (/ISO) |